FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Marc van der Planken

Research Profile

Disorders

Chemicals & Drugs

Phenomena

Bleeding Time

Procedures

Physiology

Anatomy

Blood Platelets

Concepts & Ideas

Genes & Molecular Sequences

Co-author Network

Publications

TOP 3
L Patteet; K Pieters; E Van Assche; Zwi N Berneman; A Gaddiseur; Katrien Vermeulen; I Vrelust; Marc van der Planken
A hypogranular variant of acute promyelocytic leukaemia showing a heterogenic immunophenotype with CD34, CD2, HLA-DR positivity: a case report and review of the literature.
Catherine M Moerenhout; Marc J Claeys; Steven Haine; Hielko Miljoen; Johan M Bosmans; Francine Vertessen; Katrien Kluppels; Marc van der Planken; Christiaan J Vrints
Clinical relevance of clopidogrel unresponsiveness during elective coronary stenting: experience with the point-of-care platelet function assay-100 C/ADP.
Alain Gadisseur; Marc van der Planken; Wilfried Schroyens; Zwi Berneman; Jan Jacques Michiels
Dominant von Willebrand disease type 2M and 2U are variable expressions of one distinct disease entity caused by loss-of-function mutations in the A1 domain of the von Willebrand factor gene.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Marc van der Planken (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: L Patteet; K Pieters; E Van Assche; Zwi N Berneman; A Gaddiseur; Katrien Vermeulen; I Vrelust; Marc van der Planken
A hypogranular variant of acute promyelocytic leukaemia showing a heterogenic immunophenotype with CD34, CD2, HLA-DR positivity: a case report and review of the literature.
Acta clinica Belgica 2012;67(1):34-8.
2010: Catherine M Moerenhout; Marc J Claeys; Steven Haine; Hielko Miljoen; Johan M Bosmans; Francine Vertessen; Katrien Kluppels; Marc van der Planken; Christiaan J Vrints
Clinical relevance of clopidogrel unresponsiveness during elective coronary stenting: experience with the point-of-care platelet function assay-100 C/ADP.
American heart journal 2010;159(3):434-8.
2009: Alain Gadisseur; Marc van der Planken; Wilfried Schroyens; Zwi Berneman; Jan Jacques Michiels
Dominant von Willebrand disease type 2M and 2U are variable expressions of one distinct disease entity caused by loss-of-function mutations in the A1 domain of the von Willebrand factor gene.
Acta haematologica 2009;121(2-3):145-53.
2009: Jan Jacques Michiels; Alain Gadisseur; Marc van der Planken; Wilfried Schroyens; Zwi Berneman
Laboratory and molecular characteristics of recessive von Willebrand disease type 2C (2A subtype IIC) of variable severity due to homozygous or double heterozygous mutations in the D1 and D2 domains.
Acta haematologica 2009;121(2-3):111-8.
2009: Jan Jacques Michiels; Zwi Berneman; Alain Gadisseur; Marc van der Planken; Wilfried Schroyens; Huub H D M van Vliet
Laboratory diagnosis and molecular basis of mild von Willebrand disease type 1.
Acta haematologica 2009;121(2-3):85-97.
2008: Jaimie Breugelmans; Francine Vertessen; Gerhard Mertens; Alain Gadisseur; Marc van der Planken
Multiplate whole blood impedance aggregometry: a recent experience.
Thrombosis and haemostasis 2008;100(4):725-6.
2007: Boris Mahieu; Nadia Jacobs; Sarah Mahieu; Kristine Naelaerts; Francine Vertessen; Joost Weyler; Yves Jacquemyn; Marc van der Planken
Haemostatic changes and acquired activated protein C resistance in normal pregnancy.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2007;18(7):685-8.
2007: L Daniëls; K Guerti; Katrien Vermeulen; Hendrik De Raeve; E Van Assche; Ann van de Velde; Z N Berneman; Marc van der Planken
Acute myeloid leukaemia of mixed megakaryocytic and erythroid origin: a case report and review of the literature.
Acta clinica Belgica 2007;62(5):308-14.
2007: Alain Gadisseur; Inge Vrelust; Inge Vangenechten; Reinhard Schneppenheim; Marc van der Planken
Identification of a novel candidate splice site mutation (0874 + 1G > A) in a type 3 von Willebrand disease patient.
Thrombosis and haemostasis 2007;98(2):464-6.
2007: Jan Jacques Michiels; Huub H D M van Vliet; Zwi Berneman; Alain Gadisseur; Marc van der Planken; Wilfried Schroyens; Ann van der Velden; Ulrich Budde
Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2007;13(1):14-34.
2006: Jan Jacques Michiels; Alain Gadisseur; Marc van der Planken; Wilfried Schroyens; Marianne De Maeseneer; Jan T Hermsen; Paul H Trienekens; Henk Hoogsteden; Peter M T Pattynama
Different accuracies of rapid enzyme-linked immunosorbent, turbidimetric, and agglutination D-dimer assays for thrombosis exclusion: impact on diagnostic work-ups of outpatients with suspected deep vein thrombosis and pulmonary embolism.
Seminars in thrombosis and hemostasis 2006;32(7):678-93.
2006: Jan Jacques Michiels; Zwi Berneman; Alain Gadisseur; Marc van der Planken; Wilfried Schroyens; Ann van de Velde; Huub H D M van Vliet
Classification and characterization of hereditary types 2A, 2B, 2C, 2D, 2E, 2M, 2N, and 2U (unclassifiable) von Willebrand disease.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2006;12(4):397-420.
2006: Jan Jacques Michiels; Alain Gadisseur; Marc van der Planken; Wilfried Schroyens; Ann van de Velden; Zwi Berneman
Guidelines for the evaluation of intravenous desmopressin and von Willebrand factor/factor VIII concentrate in the treatment and prophylaxis of bleedings in von Willebrand disease types 1, 2, and 3.
Seminars in thrombosis and hemostasis 2006;32(6):636-45.
2006: Jan Jacques Michiels; Zwi Berneman; Alain Gadisseur; Marc van der Planken; Wilfried Schroyens; Ulrich Budde; Huub H D M van Vliet
Immune-mediated etiology of acquired von Willebrand syndrome in systemic lupus erythematosus and in benign monoclonal gammopathy: therapeutic implications.
Seminars in thrombosis and hemostasis 2006;32(6):577-88.
2006: Ilse Mertens; Robert V Considine; Marc van der Planken; Luc F Van Gaal
Hemostasis and fibrinolysis in non-diabetic overweight and obese men and women. Is there still a role for leptin?
European journal of endocrinology / European Federation of Endocrine Societies 2006;155(3):477-84.
2006: Ilse Mertens; A Verrijken; J J Michiels; Marc van der Planken; Johannes B Ruige; Luc F Van Gaal
Among inflammation and coagulation markers, PAI-1 is a true component of the metabolic syndrome.
International journal of obesity (2005) 2006;30(8):1308-14.
2006: Jan Jacques Michiels; Zwi Berneman; Alain Gadisseur; Marc van der Planken; Wilfried Schroyens; Ann van de Velde; Huub H D M van Vliet
Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2006;12(3):277-95.
2006: Ilse Mertens; Marc van der Planken; Bob Corthouts; Luc F Van Gaal
Is visceral adipose tissue a determinant of von Willebrand factor in overweight and obese premenopausal women?
Metabolism: clinical and experimental 2006;55(5):650-5.
2006: Jan Jacques Michiels; Zwi Berneman; Dirk R Van Bockstaele; Marc van der Planken; Hendrik De Raeve; Wilfried Schroyens
Clinical and laboratory features, pathobiology of platelet-mediated thrombosis and bleeding complications, and the molecular etiology of essential thrombocythemia and polycythemia vera: therapeutic implications.
Seminars in thrombosis and hemostasis 2006;32(3):174-207.
2005: Ilse Mertens; Dominique P Ballaux; Tohru Funahashi; Yuji Matsuzawa; Marc van der Planken; An Verrijken; Johannes B Ruige; Luc F Van Gaal
Inverse relationship between plasminogen activator inhibitor-I activity and adiponectin in overweight and obese women. Interrelationship with visceral adipose tissue, insulin resistance, HDL-chol and inflammation.
Thrombosis and haemostasis 2005;94(6):1190-5.
2005: Jan Jacques Michiels; Alain Gadisseur; Marc van der Planken; Wilfried Schroyens; Marianne De Maeseneer; Jan T Hermsen; Paul H Trienekens; Henk Hoogsteden; Peter M T Pattynama
Screening for deep vein thrombosis and pulmonary embolism in outpatients with suspected DVT or PE by the sequential use of clinical score: a sensitive quantitative D-dimer test and noninvasive diagnostic tools.
Seminars in vascular medicine 2005;5(4):351-64.
2005: Jan Jacques Michiels; Alain Gadisseur; Ulrich Budde; Zwi Berneman; Marc van der Planken; Wilfried Schroyens; Ann van de Velde; Huub H D M van Vliet
Characterization, classification, and treatment of von Willebrand diseases: a critical appraisal of the literature and personal experiences.
Seminars in thrombosis and hemostasis 2005;31(5):577-601.
2005: Jan Jacques Michiels; Alain Gadisseur; Marc van der Planken; Wilfried Schroyens; Marianne De Maeseneer; Jan T Hermsen; Paul H Trienekens; Henk Hoogsteden; Peter M T Pattynama
A critical appraisal of non-invasive diagnosis and exclusion of deep vein thrombosis and pulmonary embolism in outpatients with suspected deep vein thrombosis or pulmonary embolism: how many tests do we need?
International angiology : a journal of the International Union of Angiology 2005;24(1):27-39.
2005: Marc J Claeys; Marc van der Planken; Johan M Bosmans; Jan J Michiels; Francine Vertessen; Peter Van Der Goten; Floris L Wuyts; Christiaan Vrints
Does pre-treatment with aspirin and loading dose clopidogrel obviate the need for glycoprotein IIb/IIIa antagonists during elective coronary stenting? A focus on peri-procedural myonecrosis.
European heart journal 2005;26(6):567-75.
2005: Jan Jacques Michiels; Alain Gadisseur; Marc van der Planken; Wilfried Schroyens; Zwi Berneman; Marianne De Maeseneer; Jan T Hermsen; Paul H Trienekens
Diagnosis of deep vein thrombosis: how many tests do we need?
Acta chirurgica Belgica 2005;105(1):16-25.
2004: Jan Jacques Michiels; Zwi N Berneman; Marc van der Planken; Wilfried Schroyens; Ulrich Budde; Huub H D M van Vliet
Bleeding prophylaxis for major surgery in patients with type 2 von Willebrand disease with an intermediate purity factor VIII-von Willebrand factor concentrate (Haemate-P).
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2004;15(4):323-30.
2004: S Mahieu; Francine Vertessen; Marc van der Planken
Evaluation of ADVIA 120 CSF assay (Bayer) vs. chamber counting of cerebrospinal fluid specimens.
Clinical and laboratory haematology 2004;26(3):195-9.
2003: W Engelen; Gert A Verpooten; Marc van der Planken; M F Helbert; Jean-Louis Bosmans; Marc E De Broe
Four cases of red blood cell aplasia in association with the use of mycophenolate mofetil in renal transplant patients.
Clinical nephrology 2003;60(2):119-24.
2003: Jozef De Dooy; Cecile Colpaert; Annemie J Schuerwegh; Chris H Bridts; Marc van der Planken; Margareta Ieven; Luc S De Clerck; Wim Stevens; Ludo Mahieu
Relationship between histologic chorioamnionitis and early inflammatory variables in blood, tracheal aspirates, and endotracheal colonization in preterm infants.
Pediatric research 2003;54(1):113-9.
2003: Jan Jacques Michiels; Wilfried Schroyens; W De Backer; Marc van der Planken; H Hoogsteden; Peter M T Pattynama
Non-invasive exclusion and diagnosis of pulmonary embolism by sequential use of the rapid ELISA D-dimer assay, clinical score and spiral CT.
International angiology : a journal of the International Union of Angiology 2003;22(1):1-14.
2003: steven callens; Eric Florence; Marc Philippe; Marc van der Planken; Robert Colebunders
Mixed arterial and venous thromboembolism in a person with HIV infection.
Scandinavian journal of infectious diseases 2003;35(11-12):907-8.
2003: Marc van der Planken; Marc J Claeys; Francine Vertessen; Dagmara Dilling; Johan M Bosmans; Zwi N Berneman; Jan J Michiels; Christiaan Vrints
Comparison of turbidimetric aggregation and in vitro bleeding time (PFA-100) for monitoring the platelet inhibitory profile of antiplatelet agents in patients undergoing stent implantation.
Thrombosis research 2003;111(3):159-64.
2002: Marc van der Planken; Wilfried Schroyens; Francine Vertessen; Jan J Michiels; Zwi N Berneman
Distal deep venous thrombosis in a hemophilia A patient with inhibitor and severe infectious disease, 18 days after recombinant activated factor VII transfusion.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2002;13(4):367-70.
2002: Marc J Claeys; Marc van der Planken; Jan J Michiels; Francine Vertessen; Dagmara Dilling; Johan M Bosmans; Christiaan Vrints
Comparison of antiplatelet effect of loading dose of clopidogrel versus abciximab during coronary intervention.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2002;13(4):283-8.
2002: Jan Jacques Michiels; Ann van de Velde; Huub H D M van Vliet; Marc van der Planken; Wilfried Schroyens; Zwi Berneman
Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.
Seminars in thrombosis and hemostasis 2002;28(2):111-32.
2002: Jan Jacques Michiels; H Kasbergen; R Oudega; F van der Graaf; Marianne De Maeseneer; Marc van der Planken; Wilfried Schroyens
Exclusion and diagnosis of deep vein thrombosis in outpatients by sequential noninvasive tools.
International angiology : a journal of the International Union of Angiology 2002;21(1):9-19.
2001: J Van den Bossche; Francine Vertessen; Marc van der Planken
Reticulocyte enumeration on Bayer Advia 120 is not influenced by malaria parasites.
Acta clinica Belgica 2001;56(6):378-9.
2001: Ilse Mertens; Marc van der Planken; Bob Corthouts; Machteld Wauters; FW Peiffer; Ivo H De Leeuw; Luc Van Gaal
Visceral fat is a determinant of PAI-1 activity in diabetic and non-diabetic overweight and obese women.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 2001;33(10):602-7.
2001: Jan Jacques Michiels; Ulrich Budde; Marc van der Planken; Huub H D M van Vliet; Wilfried Schroyens; Zwi Berneman
Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management.
Best practice & research. Clinical haematology 2001;14(2):401-36.
2001: Jan Jacques Michiels; Wilfried Schroyens; Zwi Berneman; Marc van der Planken
Acquired von Willebrand syndrome type 1 in hypothyroidism: reversal after treatment with thyroxine.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2001;7(2):113-5.
2001: Jan Jacques Michiels; Wilfried Schroyens; Marc van der Planken; Zwi Berneman
Acquired von Willebrand syndrome in systemic lupus erythematodes.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2001;7(2):106-12.
2001: J Michiels; Wilfried Schroyens; Zwi Berneman; Marc van der Planken
Atypical variant of acquired von Willebrand syndrome in Wilms tumor: is hyaluronic acid secreted by nephroblastoma cells the cause?
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2001;7(2):102-5.
2000: Marc van der Planken; Francine Vertessen; Jan Vertommen; Wendy Engelen; Zwi N Berneman; I De Leeuw
Platelet prothrombinase activity, a final pathway platelet procoagulant activity, is overexpressed in type 1 diabetes: no relationship with mean platelet volume or background retinopathy.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2000;6(2):65-8.
2000: Jan Croonenberghs; L Delmeire; Robert Verkerk; AH Lin; A Meskal; Hugo Neels; Marc van der Planken; Simon Scharpe; Dirk Deboutte; G Pison; Michael Maes
Peripheral markers of serotonergic and noradrenergic function in post-pubertal, caucasian males with autistic disorder.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2000;22(3):275-83.
1999: A Meskal; Francine Vertessen; Marc van der Planken; Zwi N Berneman
The platelet function analyzer (PFA-100) may not be suitable for monitoring the therapeutic efficiency of von willebrand concentrate in type III von willebrand disease.
Annals of hematology 1999;78(9):426-30.
1999: Michael Maes; AH Lin; Robert Verkerk; L Delmeire; A Van Gastel; Marc van der Planken; Simon Scharpé
Serotonergic and noradrenergic markers of post-traumatic stress disorder with and without major depression.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1999;20(2):188-97.
1999: C Song; M Vandewoude; Wim Stevens; Luc S De Clerck; Marc van der Planken; A Whelan; H Anisman; A Dossche; Michael Maes
Alterations in immune functions during normal aging and Alzheimer's disease.
Psychiatry research 1999;85(1):71-80.
1999: Marc van der Planken; Francine Vertessen; E Mortelmans; Dirk R Van Bockstaele; L Muylle; Gerhard Mertens; Zwi N Berneman
The evolution of platelet procoagulant activity of remnant platelets in stored platelet concentrates prepared by the platelet-rich plasma method and the buffy coat method.
Annals of hematology 1999;78(1):1-7.
1998: Michael Maes; Marc van der Planken; A Van Gastel; K Bruyland; F Van Hunsel; Hugo Neels; D Hendriks; Annick Wauters; P Demedts; A Janca; Simon Scharpé
Influence of academic examination stress on hematological measurements in subjectively healthy volunteers.
Psychiatry research 1998;80(3):201-12.
1996: Michael Maes; Marc van der Planken; A Van Gastel; R Desnyder
Blood coagulation and platelet aggregation in major depression.
Journal of affective disorders 1996;40(1-2):35-40.